Form 4 Tracker
Susan Bobulsky

Chief Commercial Officer, MRD · 11 filings · Latest: Oct 6, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
Susan BobulskyChief Commercial Officer, MRDOct 6, 2026
Sale
$30.006,444$193.3K389,350
ADPT
SUSAN BOBULSKY—Oct 6, 2026
Proposed Sale
$29.846,444$192.3K—
ADPT
Susan BobulskyChief Commercial Officer, MRDSep 15, 2026
Sale
$27.001,195$32.3K395,794
ADPT
SUSAN BOBULSKY—Sep 15, 2026
Proposed Sale
$24.781,195$29.6K—
ADPT
Susan BobulskyChief Commercial Officer, MRDAug 10, 2026
Sale
$25.003,000$75.0K396,989
ADPT
SUSAN BOBULSKY—Aug 10, 2026
Proposed Sale
$24.933,000$74.8K—
ADPT
Susan BobulskyChief Commercial Officer, MRDJul 30, 2026
Sale
$24.001,299$31.2K399,989
ADPT
SUSAN BOBULSKY—Jul 30, 2026
Proposed Sale
$22.561,299$29.3K—
ADPT
Susan BobulskyChief Commercial Officer, MRDJul 16, 2026
Sale
$23.005,000$115.0K401,288
ADPT
SUSAN BOBULSKY—Jul 16, 2026
Proposed Sale
$22.905,000$114.5K—
ADPT
Susan BobulskyChief Commercial Officer, MRDJul 1, 2026
Sale
$22.00487$10.7K406,288
ADPT
SUSAN BOBULSKY—Jul 1, 2026
Proposed Sale
$21.45487$10.4K—
ADPT
Susan BobulskyChief Commercial Officer, MRDJun 25, 2026
Sale
$20.505,000$102.5K406,775
ADPT
SUSAN BOBULSKY—Jun 25, 2026
Proposed Sale
$19.345,000$96.7K—
ADPT
Susan BobulskyChief Commercial Officer, MRDJun 11, 2026
Sale
$19.005,000$95.0K411,775
ADPT
SUSAN BOBULSKY—Jun 11, 2026
Proposed Sale
$17.075,000$85.3K—
ADPT
Susan BobulskyChief Commercial Officer, MRDJun 4, 2026
Sale
$18.0011,000$198.0K416,775
ADPT
SUSAN BOBULSKY—Jun 4, 2026
Proposed Sale
$15.9911,000$175.9K—
ADPT
BOBULSKY SUSAN—Mar 11, 2026
Proposed Sale
$14.5241,338$600.2K—
ADPT
Susan BobulskyChief Commercial Officer, MRDMar 11, 2026
Sale
$13.1741,338$544.4K427,775